ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference

YONKERS, NY — (Marketwired) — 09/03/14 — ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, announced today that Julia P. Gregory, the Company’s chief executive officer and Barry Kappel, the Company’s senior vice president of business development, will present a corporate overview at the Rodman & Renshaw 16th Annual Healthcare Conference in New York, NY on Wednesday, September 10 at 9:30 AM EDT. Ms. Gregory and Dr. Kappel will discuss ContraFect’s novel approach to the treatment of drug-resistant Staphylococcus aureus infections and clinical plans for its lead product, CF-301.

This entry was posted in Recent Development News: Q3 – 2014. Bookmark the permalink.